FDA Launches Expedited IND Pilot to Shorten the Path to First-in-Human Drug Trials
The FDA has opened applications for its Expedited IND Pilot, pairing drug sponsors with qualified research institutions and rolling IND reviews to shorten the up-to-two-year path to first-in-human trials in…
